Clinical Trial Update: STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intravenous enoxaparin (Lovenox) versus unfractionated heparin during primary PCI for STEMI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Heparin (unfractionated heparin)
• Lovenox (enoxaparin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Primary PCI - STEMI | Phase 3 | Status: COMPLETED